BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 9, 2020
View Archived Issues
Chimeric BET degrader-antibody conjugate shows improved PK and in vivo antitumor activity
Read More
Health Canada approves phase I study of Cardiol's ultra-pure CBD formulation
Read More
EMILIN3 and INA identified as novel markers of LG-ESS using comparative proteomics
Read More
11beta-HSD1 as a new marker of response to IC blockade therapy in NSCLC
Read More
Mutations in PIK3-ATK-MTOR pathway linked to poor prognosis in oligodendrogliomas
Read More
Rapamycin, telomeres have unexpectedly complex relationship
Read More
Serine improves memory in Alzheimer's mouse model
Read More
From junk to noncoding to coding
Read More
Adipophilin tied to poor prognosis in malignant melanoma
Read More
Asceneuron patents new OGA inhibitors
Read More
Shanghai Allist Pharmaceutical discloses EGFR mutant inhibitors
Read More
Nanjing TransThera Biosciences identifies TAM family kinases inhibitors
Read More
CytoDyn submits IND application to study leronlimab for COVID-19 respiratory complications
Read More
Algernon makes ifenprodil available for compassionate use for coronavirus
Read More
ALRN-6924 upregulates P21 expression in AML/MDS patients
Read More
FDA approves Isturisa for Cushing's disease
Read More
Compugen releases new data from phase I study of COM-701 in advanced solid tumors
Read More
Netherlands Cancer Institute plans phase I/Ib study of RMC-4630 with ERK inhibitor
Read More
Ascentage cleared to begin new trials of APG-2575 in U.S. and China
Read More